Literature DB >> 21691484

Cardiac tamponade after minimally invasive coronary artery bypass graft.

Erica Chiu Liang1, Jennifer Rossi, Laleh Gharahbaghian.   

Abstract

Entities:  

Year:  2011        PMID: 21691484      PMCID: PMC3088387     

Source DB:  PubMed          Journal:  West J Emerg Med        ISSN: 1936-900X


× No keyword cloud information.
A 61-year-old man presented to the emergency department (ED) with gradual onset shortness of breath exacerbated by lying flat three weeks after undergoing minimally invasive three-vessel coronary artery bypass grafting (CABG). Due to a history of lower extremity deep venous thrombosis, he was taking warfarin, which was held pre-operatively and restarted on post-operative day three along with clopidogrel and aspirin. Prothrombin time was not checked prior to discharge. His vital signs in the ED were notable for an oxygen saturation of 84% on room air improving to 93% with supplemental oxygen. Laboratory testing was remarkable for an international normalization ratio of 24.3, and electrocardiogram showed lateral T wave inversions in V5–V6 but was otherwise unremarkable. A bedside echocardiogram was performed (Figure).
Figure

Bedside echocardiogram – subxiphoid view (SX) of heart. Loculated anterior pericardial effusion (PCE) is evident (thin blue arrow) showing obliteration of right heart. Left ventricle (LV) and atrium (LA) is also visible (red arrow).

Pericardial effusion is a known complication of cardiac surgery found in up to 85% of patients by postoperative day two and usually begins in the posterior pericardial space in a supine patient.1 Persistent pericardial effusion after post-operative day 15 is less common but is associated with a higher incidence of cardiac tamponade, especially in patients receiving anticoagulation therapy.2 Minimally-invasive CABG, first described in the 1990s, involves access to the heart via a small anterior thoracotomy incision; however, pericardial effusion and cardiac tamponade are still known complications.3,4 Our patient had a loculated anterior pericardial effusion causing obliteration of the right atrium with diastolic collapse of the right ventricle causing heart failure and his initial complaint of shortness of breath. As shown in the image, the loculations prevented fluid from surrounding the entire heart. His coagulopathy was reversed with 6 units of FFP and 10 units of subcutaneous Vitamin K. Cardiology was immediately consulted, and the patient was taken for emergent echocardiographically-guided pericardiocentesis. A pigtail catheter was placed in the pericardial space with 500 mL of bloody fluid return. The patient did well post-procedure and was discharged on post-procedure day five.
  4 in total

1.  Delayed cardiac tamponade after minimally invasive direct coronary artery bypass.

Authors:  H Hirose; A Amano; A Takahashi; N Nagano
Journal:  Eur J Cardiothorac Surg       Date:  1999-10       Impact factor: 4.191

2.  Cardiac tamponade following minimally invasive direct coronary artery bypass.

Authors:  R R Lazzara; J T Hanlon; B A McLellan; D T Combs; E K Young; M P Sheehan
Journal:  Chest       Date:  1997-10       Impact factor: 9.410

3.  The incidence and natural history of pericardial effusion after cardiac surgery--an echocardiographic study.

Authors:  L B Weitzman; W P Tinker; I Kronzon; M L Cohen; E Glassman; F C Spencer
Journal:  Circulation       Date:  1984-03       Impact factor: 29.690

4.  Evolution of the postoperative pericardial effusion after day 15: the problem of the late tamponade.

Authors:  Philippe Meurin; Hélène Weber; Nathalie Renaud; Fabrice Larrazet; Jean Yves Tabet; Pierre Demolis; Ahmed Ben Driss
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

  4 in total
  1 in total

1.  Emergency department point-of-care ultrasonography improves time to pericardiocentesis for clinically significant effusions.

Authors:  Evan Avraham Alpert; Uri Amit; Larisa Guranda; Rafea Mahagna; Shamai A Grossman; Ariel Bentancur
Journal:  Clin Exp Emerg Med       Date:  2017-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.